Grant: Engage Plus Grants Program
Simon Fraser University
$12,500.00
Enhancing quality assurance of medical marijuana using DNA fingerprinting
EF 2015-16
Résumé
Marijuana (Cannabis sativa L.) is increasingly being recognized for its properties in treating a number of
human diseases, such as multiple sclerosis, chronic pain, seizures and PTSD. Marijuana plants may be initiated
from seeds but more commonly are propagated from vegetative cuttings originating from stock plants (mother
plants). Seeds are used when a new genetic line (strain) is being considered, but is subject to variation in
phenotypic characteristics in the offspring due to segregation. It is not uncommon for a potential mix-up of
genetic lines to occur during commercial production, or for seeds or vegetative propagation to give rise to
unusual phenotypes. This creates a problem for quality assurance as well as for monitoring a particular line for
genetic stability over time. The availability of a DNA fingerprinting method that can be used to distinguish
among selected lines, as well as to study the extent of genetic variation among a wide range of lines and seed
sources, would be invaluable as a rapid screen for quality assurance and genetic fidelity. In the preceding
Engage grant, a set of 7 ISSR primers was identified that produced distinct banding patterns when used with a
broad range of DNA sources of Cannabis. This primer set showed that a significant level of genetic variation
exists amongst 40 strains of medical marijuana, something not previously reported. An additional set of
primers (SFU1, SFU2) was developed that could distinguish male from female plants of marijuana. The
objectives of this research are to: 1) Determine the variables affecting the utility of a plant sex testing kit based
on primers SFU1-SFU2 developed in the previous work; 2) Continue to evaluate the set of 7 ISSR primers for
suitability to develop a DNA fingerprinting test kit that could be utilized commercially to identify select
marijuana strains; 3) Assess the conditions that can influence the variability of results in objectives (1) and (2)
above; 4) Conduct DNA sequencing to verify the relationships among the different marijuana strains, as well as
between female and male plants, and compare the results to the Cannabis genome sequence available on-line
and Genbank sequences.
Programme
Engage Plus Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
485869-2015
Name nom
Punja, Zamir
Department département
Biological Sciences
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1209
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Agriculture
Area of application fr
Agriculture
Research subject code
4900
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Plant and treebiology
Research subject fr
Biologie végétale et des arbres
Partie
1
Nb partie
1
Application title
Enhancing quality assurance of medical marijuana using DNA fingerprinting
Keyword
NSERC
Application summary
Marijuana (Cannabis sativa L.) is increasingly being recognized for its properties in treating a number of
human diseases, such as multiple sclerosis, chronic pain, seizures and PTSD. Marijuana plants may be initiated
from seeds but more commonly are propagated from vegetative cuttings originating from stock plants (mother
plants). Seeds are used when a new genetic line (strain) is being considered, but is subject to variation in
phenotypic characteristics in the offspring due to segregation. It is not uncommon for a potential mix-up of
genetic lines to occur during commercial production, or for seeds or vegetative propagation to give rise to
unusual phenotypes. This creates a problem for quality assurance as well as for monitoring a particular line for
genetic stability over time. The availability of a DNA fingerprinting method that can be used to distinguish
among selected lines, as well as to study the extent of genetic variation among a wide range of lines and seed
sources, would be invaluable as a rapid screen for quality assurance and genetic fidelity. In the preceding
Engage grant, a set of 7 ISSR primers was identified that produced distinct banding patterns when used with a
broad range of DNA sources of Cannabis. This primer set showed that a significant level of genetic variation
exists amongst 40 strains of medical marijuana, something not previously reported. An additional set of
primers (SFU1, SFU2) was developed that could distinguish male from female plants of marijuana. The
objectives of this research are to: 1) Determine the variables affecting the utility of a plant sex testing kit based
on primers SFU1-SFU2 developed in the previous work; 2) Continue to evaluate the set of 7 ISSR primers for
suitability to develop a DNA fingerprinting test kit that could be utilized commercially to identify select
marijuana strains; 3) Assess the conditions that can influence the variability of results in objectives (1) and (2)
above; 4) Conduct DNA sequencing to verify the relationships among the different marijuana strains, as well as
between female and male plants, and compare the results to the Cannabis genome sequence available on-line
and Genbank sequences.